Endocrine and Metabolic Disorders and Sleep

Sleep: A Comprehensive Handbook

Volumn , Issue , 2005, Pages 745-757

  Vgontzas, Alexandros N ^a   Pejovic, Slobodanka ^b   Chrousos, George P ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endocrine and metablic disorders and sleep; Obesity and sleep apnea; Polycystic ovary syndrome (PCOS)

Indexed keywords

EID: 84891529170     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471751723.ch98     Document Type: Chapter

References (120)

1. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850(2004).
2. Gastaut H, Tassinari CA, Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res 2:167-186(1966).
3. Guilleminault C, van den Hoed J, Mitler MM. Clinical overview of the sleep apnea syndromes. In: Guilleminault C, Dement WC (Eds), Sleep Apnea Syndromes. Alan R Liss, New York, 1978, pp 1-12.
4. Lugaresi E, Coccagna G, Montavani M. Hypersomnia with periodic apneas. In: Weitzman E (Ed), Advances in Sleep Research. Spectrum Publications, New York, 1978, p 4.
5. Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705-1711(1994).
6. Young T, Palta M, Dempsey J, et al. The occurrence of sleepdisordered breathing among middle aged adults. N Engl J Med 328:1203-1205(1993).
7. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:144-148(1998).
8. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnea syndrome in obese subjects. J Intern Med 241:11-18(1997).
9. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151-1158(2000).
10. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143(1991).
11. Bixler EO, Vgontzas AN, Lin H-M, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 160: 2289-2295(2000).
12. Vgontzas AN, Kales A. Sleep and its disorders. Annu Rev Med 50:387-400(1999).
13. Rasheid S, Banasiak M, Gallagher SF, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 13:58-61(2003).
14. Valencia-Flores M, Orea A, Herrera M, et al. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg 14:755-762(2004).
15. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Treatment of visceral fat obesity. Int J Obes 15(Suppl 2):59-65(1991).
16. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767-2774(2000).
17. Shimomura I, Tokunaga K, Kotani K, et al. Marked reduction of acyl-CoA synthetase activity and mRNA in intraabdominal visceral fat by physical exercise. Am J Physiol 265(1 Pt 1): E44-E50(1993).
18. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1:e62(2004).
19. Vorona RD, Winn MP, Babineau TW, et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165:25-30(2005).
20. Spiegel K, Tasali E, Penev P, et al. Brief communication:sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141:846-856(2004).
21. Hasler G, Buysse DJ, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27:661-666(2004).
22. Gupta NK, Mueller WH, Can W, et al. Is obesity associated with poor sleep quality in adolescents? Am J Hum Biol 14:762-768(2002).
23. Sekine M, Yamagami T, Handa K, et al. A dose-response relationship between short sleeping hours and childhood obesity:results of the Toyama Birth Cohort Study. Child Care Health Dev 28:163-170(2002).
24. von Kries R, Toschke AM, Wurmser H, et al. Reduced risk for overweight and obesity in 5- and 6-y-old children by duration of sleep-a cross-sectional study. Int J Obes Relat Metab Disord 26:710-716(2002).
25. Vgontzas AN, Bixler EO, Tan T-L, et al. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 158:1333-1337(1998).
26. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 25:669-675(2001).
27. Resta O, Roschino Barbaro MP, Bonfitto P, et al. Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 253:536-543(2003).
28. Bixler EO, Vgontzas AN, Lin H-M, et al. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes and depression. J. Clin Endocrinol Metab. Aug;90:4510-4515(2005).
29. Vela-Bueno A, Kales A, Soldatos CR. Sleep in the Prader-Willi syndrome. Arch Neurol 41:294-296(1984).
30. Vgontzas AN, Kales A, Seip J, et al. Relationship of sleep abnormalities to patient genotypes in Prader-Willi syndrome. Am J Med Genet 67:478-482(1996).
31. Vgontzas AN, Bixler EO, Kales A, Vela-Bueno A. Prader-Willi syndrome: effects of weight loss on sleep-disordered breathing, daytime sleepiness and REM sleep disturbance. Acta Paediatr 84:813-814(1995).
32. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness:role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316(1997).
33. Vgontzas AN, Zoumakis E, Lin HM, et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 89:4409-4413(2004).
34. Van Cauter E, Spiegel K. Hormones and metabolism during sleep. In: Schwartz WJ (Ed), Sleep Science: Integrating Basic Research and Clinical Practice (Monographs in Clinical Neuroscience), Vol 15. S. Karger Publishers, Farmington, CT, 1997, pp 144-174.
35. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435-1439(1999).
36. Gislason T, Almqvist M. Somatic diseases and sleep complaints. Acta Med Scand 221:475-481(1987).
37. Sridhar GR, Madhu K. Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract 23:183-186(1994).
38. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26:380-384(2003).
39. Lamond N, Tiggemann M, Dawson D. Factors predicting sleep disruption in type II diabetes. Sleep 23(3):415-416(2000).
40. Matyka KA, Crawford C, Wiggs L, et al. Alterations in sleep physiology in young children with insulin-dependent diabetes mellitus: relationship to nocturnal hypoglycemia. J Pediatr 137(20):233-238(2000).
41. Mondini S, Guilleminault C. Abnormal breathing patterns during sleep in diabetes. Ann Neurol 17(4):391-395(1985).
42. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79(6):1681-1685(1994).
43. Ip SM, Tsang WT, Lam WK, et al. Obstructive sleep apnea syndrome: an experience in Chinese adults in Hong Kong. Chin Med J (Engl) 111(3):257-260(1998).
44. Ficker JH, Dertinger SH, Siegfried W. Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J 11(1):14-19(1998).
45. Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248:13-20(2000).
46. Al-Delaimy WK, Manson JE, Willett WC, et al. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155:387-393(2002).
47. Honda Y, Doi Y, Ninomiya R, Ninomiya C. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 9(1 Pt 2):254-259(1986).
48. Roberts HJ. Obesity due to the syndrome of narcolepsy and diabetogenic hyperinsulinism: clinical and therapeutic observations in 252 patients. J Am Geriat Soc 15:721-743(1967).
49. Okun ML, Giese S, Lin L, Einen M, Mignot E, Coussons-Read ME. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun. Jul;18(4):326-332(2004).
50. Garvey WT, Hermayer KL. Clinical implications of the insulin resistance syndrome. Clin Cornerstone 1(3):13-28(1998).
51. Reaven GM. Insulin resistance and human disease: a short story. J Basic Clin Physiol Pharmacol 9:387-406(1998).
52. Bixler EO, Vgontzas AN, Lin H-M, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med 162:1-6(2001).
53. Strohl KP, Novak RD, Singer W, et al. Insulin levels, blood pressure and sleep apnea. Sleep 17:614-618(1994).
54. Davies RJO, Turner R, Crosby J, Stradling JR. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 3:180-185(1994).
55. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154:170-174(1996).
56. Vgontzas AN, et al. Metabolic Disturbances in Obesity Versus Sleep Apnoea: The Importance of Visceral Obesity and Insulin Resistance of Internal Medicine 254:32-44(2003). Blackwell Publishing, London, 2003.
57. Vgontzas AN, et al. Sleep Apnea Is a Manifestation of the Metabolic Syndrome. Elsevier, New York. Sleep Med Rev 9:211-224(2005).
58. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome:prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163:427-436(2003).
59. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676(2002).
60. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682(2002).
61. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521-530(2004).
62. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86:517-520(2001).
63. Bixler EO, Kales A, Jacoby JA, et al. Nocturnal sleep and wakefulness: effects of age and sex in normal sleepers. Int J Neurosci 23:33-42(1984).
64. Williams RL, Karacan I, Hursch C. EEG of Human Sleep:Clinical Applications. John Wiley & Sons, Hoboken, NJ, 1974.
65. Ehlers CL, Kupfer DJ. Slow-wave sleep: do young adult men and women age differently? J Sleep Res 6:211-215(1997).
66. Hume KI, Van F, Watson A. A field study of age and gender differences in habitual adult sleep. J Sleep Res 7:85-94(1998).
67. Carrier J, Land S, Buysse DJ, et al. The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). Psychophysiology 38:232-242(2001).
68. Bixler EO, Vgontzas AN, Lin H-M, et al. Normal sleep and sleep stage patterns: effects of age, BMI and gender. Sleep 26(Suppl):A61-A62(2003).
69. Redline S, Bonekat W, Gottlieb D, et al. Sleep stage distributions in the sleep heart health study (SHHS) cohort. Sleep 21(Suppl):210(1998).
70. Sandblom RE, Matsumoto AM, Schoene RB, et al. Obstructive sleep apnea induced by testosterone administration. N Engl J Med 308:506-510(1983).
71. Schneider BK, Pickett CK, Zwillich CW. Influence of testosterone on breathing during sleep. J Appl Physiol 61:618-623(1986).
72. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med 149:530-532(1994).
73. Johnson MW, Anch AM, Remmers JE. Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration. Am Rev Respir Dis 129:1023-1025(1984).
74. Dexter DD, Dovre EJ. Obstructive sleep apnea due to endogenous testosterone production in a woman. Mayo Clin Proc 73:246-248(1988).
75. Liu PY, Yee B, Wishart SM, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older man. J Clin Endocrinol Metab 88:3605-3613(2003).
76. Stewart DA, Grunstein RR, Berthon-Jones M, et al. Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 146:1389-1393(1992).
77. Grunstein RR, Handelsman DJ, Lawrence S, et al. Neuroendocrine dysfunction in sleep apnea: reversal by nasal continuous positive airway pressure. J Clin Endocrinol Metab 68:352-358(1989).
78. White D, Douglas N, Pickett C, et al. Hypoxic ventilatory response during sleep in normal premenopausal women. Am Rev Respir Dis 126:530-553(1982).
79. Block AJ, Wynne JW, Boysen PG, et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 70:506-510(1981).
80. Shahar E, Redline S, Young T, et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 167:1186-1192(2003).
81. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 167:1181-1185(2003).
82. Margolis KL, Bonds DE, Rodabough RJ, et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47:1175-1187(2004).
83. Dunaif A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev 18:774-800(1997).
84. Fogel RBMA, Pillar G, Pittman SD, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:1175-1178(2001).
85. Gopal M, Duntley S, Uhles M, et al. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3:401-404(2004).
86. Young T, Rabago D, Zgierska A, et al. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 26:667-672(2003).
87. Moe KE, Larsen LH, Vitiello MV, et al. Estrogen replacement therapy moderates the sleep disruption associated with nocturnal blood sampling. Sleep 24:886-894(2001).
88. Pejovic S, Bixler EO, Lin H-M, et al. Young women compared to men are more resilient to the sleep disturbing effects of external stressors. Abstract presented at the APSS 19th Annual Meeting, Denver, CO, 2005.
89. Chrousos GP, Kattah JC, Beck RW, Cleary PA and the Optic Neuritis Study Group. Side effects of glucocorticoid treatment. JAMA 269:2110-2112(1993).
90. Opp M, Obál F Jr, Krueger JM. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 257:R528-R535(1989).
91. Bierwolf C, Struve K, Marshall L, et al. Slow wave sleep drives inhibition of pituitary-adrenal secretion in humans. Neuroendocrinology 9:479-484(1997).
92. Vgontzas AN, Mastorakos G, Bixler EO, et al. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin Endocrinol (Oxf) 51:205-215(1999).
93. Weitzman ED, Zimmerman JC, Czeisler CA, Ronda J. Cortisol secretion is inhibited during sleep in normal men. J Clin Endocrinol Metab 56:352-358(1983).
94. Vgontzas AN, Bixler EO, Lin H-M, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:3787-3794(2001).
95. Rodenbeck A, Huether G, Ruther E, et al. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 324:159-163(2002).
96. Rodenbeck A, Cohrs S, Jordan W, et al. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology 170:423-428(2003).
97. Bixler EO, Vgontzas AN, Lin H-M, et al. Insomnia in central Pennsylvania. J Psychosom Res 53:589-592(2002).
98. Vgontzas AN, Bixler EO, Wittman AM, et al. Middle-aged men show higher sensitivity of their sleep to the arousing effects of corticotropin-releasing hormone than young men:clinical implications. J Clin Endocrinol Metab 86:1489-1495(2001).
99. Shipley JE, Schteingart DE, Tandon R, et al. Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep 15:514-518(1992).
100. Friedman TC, García-Borreguero D, Hardwick D, et al. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome. Neuroendocrinology 60:626-634(1994).
101. García-Borreguero D, Wehr TA, Larrosa O, et al. Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J Clin Endocrinol Metab 85:4201-4206(2000).
102. Gillin JC, Jacobs LS, Fram DH, Snyder F. Acute effect of a glucocorticoid on normal human sleep. Nature 237:398-399(1972).
103. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: Does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab 81:2303-2306(1996).
104. Reincke M, Heppner C, Petzke F, et al. Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. Neuroimmunomodulation 1:14-22(1994).
105. Grunstein RR, Ho KY, Sullivan CE. Acromegaly and sleep apnea. Ann Intern Med 115:527-532(1991).
106. Rosenow F, Reuter S, Deuss U, et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 45:563-569(1996).
107. Hochban W, Ehlenz K, Conradt R, et al. Obstructive sleep apnea in acromegaly: the role of craniofacial changes. Eur Respir J 14:196-202(1999).
108. Cadieux RJ, Kales A, Santen RJ, et al. Endoscopic findings in sleep apnea associated with acromegaly. J Clin Endocrinol Metab 55:18-22(1982).
109. Grunstein RR. Metabolic aspects of sleep apnea. Sleep 19:S218-S220(1996).
110. Pelttari L, Rauhala E, Polo O, et al. Upper airway obstruction in hypothyroidism. J Intern Med 236:177-181(1994).
111. Kapur VK, Koepsell TD, deMaube J, et al. Association of hypothyroidism and obstructive sleep apnea. Am J Respir Crit Care Med 158:1379-1383(1998).
112. Winkelman JW, Goldman H, Piscatelli N, et al. Are thyroid function tests necessary in patients with suspected sleep apnea? Sleep 19:790-793(1996).
113. Resta O, Pannacciulli N, Di Gioia G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 14:248-253(2004).
114. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137(1998).
115. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome." Endocr Rev 3:164-217(1982).
116. Grunstein RR, Sullivan CE. Hypothyroidism and sleep apnea: mechanisms and management. Am J Med 85:775-779(1988).
117. Hayashi M, Araki S, Kohyama J, et al. Sleep development in children with congenital and acquired hypothyroidism. Brain Dev 19:43-49(1997).
118. Ruiz-Primo E, Jurado JL, Solis H, et al. Polysomnographic effects of thyroid hormones in primary myxedema. Electroencephalogr Clin Neurophysiol 53:559-564(1982).
119. Huang YR, Wang GH. Study on quality of sleep and mental health in patients with hyperthyroidism. Chung Hua Hu Li Tsa Chih 32:435-439(1997).
120. Dunleavy DLF, Oswald I, Brown P, Strong JA. Hyperthyroidism, sleep and growth hormone. Electroencephalogr Clin Neurophysiol 36:259-263(1974).